Transaction DateRecipientSharesTypePriceValue
13th August 2020Ted William Karkus50,000Open or private sale$2.75$137,500.00
13th August 2020Louis Md Gleckel50,000Open or private purchase$2.75$137,500.00
9th July 2020Ted William Karkus54,150Bona fide gift$0.00
9th July 2020Ted William Karkus28,600Bona fide gift$0.00
9th July 2020Ted William Karkus25,550Bona fide gift$0.00
1st July 2020Louis Md Gleckel7,878Grant/award etc.$1.43$11,265.54
1st July 2020Jason Michael Barr4,727Grant/award etc.$1.43$6,759.61
1st April 2020Jason Michael Barr3,641Grant/award etc.$1.85$6,735.85
1st April 2020Louis Md Gleckel6,068Grant/award etc.$1.85$11,225.80
26th March 2020Ted William Karkus100,000Open or private sale$1.75$175,000.00
Pro Phase Labs
Pro Phase Labs logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.


ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer consumer healthcare products. Its products include TK supplement. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989.


Ticker: PRPH
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
SEC Central Index Key (CIK): 868278
Employees: 47
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals